Mansinho, A.; Ferreira, A.R.; Casimiro, S.; Alho, I.; Vendrell, I.; Costa, A.L.; Sousa, R.; Abreu, C.; Pulido, C.; Macedo, D.;
et al. Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases. Int. J. Mol. Sci. 2019, 20, 695.
https://doi.org/10.3390/ijms20030695
AMA Style
Mansinho A, Ferreira AR, Casimiro S, Alho I, Vendrell I, Costa AL, Sousa R, Abreu C, Pulido C, Macedo D,
et al. Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases. International Journal of Molecular Sciences. 2019; 20(3):695.
https://doi.org/10.3390/ijms20030695
Chicago/Turabian Style
Mansinho, André, Arlindo R. Ferreira, Sandra Casimiro, Irina Alho, Inês Vendrell, Ana Lúcia Costa, Rita Sousa, Catarina Abreu, Catarina Pulido, Daniela Macedo,
and et al. 2019. "Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases" International Journal of Molecular Sciences 20, no. 3: 695.
https://doi.org/10.3390/ijms20030695
APA Style
Mansinho, A., Ferreira, A. R., Casimiro, S., Alho, I., Vendrell, I., Costa, A. L., Sousa, R., Abreu, C., Pulido, C., Macedo, D., Pacheco, T. R., Correia, L., & Costa, L.
(2019). Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases. International Journal of Molecular Sciences, 20(3), 695.
https://doi.org/10.3390/ijms20030695